Literature DB >> 30761612

Association of low alanine aminotransferase with loss of independence or death: A 5-year population-based cohort study.

Hajime Yamazaki1, Tsukasa Kamitani1, Takeshi Matsui2, Yosuke Yamamoto1, Shunichi Fukuhara1.   

Abstract

BACKGROUND AND AIM: Alanine aminotransferase (ALT) is an important enzyme for amino acid metabolism and gluconeogenesis, and low ALT is an indicator of vitamin B6 deficiency. However, it is unknown whether individuals with low ALT are likely to develop loss of independence (LOI) or death. We investigated the association of low ALT with LOI or death in the elderly.
METHODS: Between 2008 and 2010, 2,484 elderly individuals (≥ 65 years old) without functional dependency from the Locomotive Syndrome and Health Outcomes in the Aizu Cohort Study were enrolled. Based on baseline ALT values, the participants were divided into the following groups: ALT < 10 (n = 73), 10-20 (n = 1,372), 20-30 (reference, n = 734), 30-40 (n = 201), and ≥ 40 (n = 104) U/L groups. LOI was defined as requiring complete support for basic activities of daily living, which is care levels 3-5 in Japanese long-term care insurance certifications. The hazard ratios of LOI or death were estimated by Cox proportional hazard models adjusted for potential confounders.
RESULTS: During the median follow-up period of 5.75 (interquartile range 4.85-5.83) years, LOI or death occurred in 195 participants (7.85%). Compared with ALT 20-30 U/L, low ALT was associated with LOI or death (multivariable adjusted hazard ratios [95% confidence intervals]: 3.02 [1.57-5.81] and 1.55 [1.07-2.24] in ALT < 10 and 10-20 U/L groups, respectively), while high ALT was not (1.29 [0.72-2.31] and 1.49 [0.68-3.25] in ALT 30-40 and ≥ 40 U/L groups, respectively).
CONCLUSIONS: Clinicians should be aware of not only high ALT, indicating liver injury, but also low ALT associated with LOI or death.
© 2019 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  ALT; disability; liver enzymes; mortality

Mesh:

Substances:

Year:  2019        PMID: 30761612     DOI: 10.1111/jgh.14631

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  5 in total

1.  Low Liver Enzymes and Risk of Dementia: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Yifei Lu; James R Pike; Elizabeth Selvin; Thomas Mosley; Priya Palta; A Richey Sharrett; Alvin Thomas; Laura Loehr; A Sidney Barritt; Ron C Hoogeveen; Gerardo Heiss
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.160

Review 2.  Risk Factors of Long-Term Care Insurance Certification in Japan: A Scoping Review.

Authors:  Shuko Takahashi; Yuki Yonekura; Nobuyuki Takanashi; Kozo Tanno
Journal:  Int J Environ Res Public Health       Date:  2022-02-14       Impact factor: 3.390

3.  Association of kyphotic posture with loss of independence and mortality in a community-based prospective cohort study: the Locomotive Syndrome and Health Outcomes in Aizu Cohort Study (LOHAS).

Authors:  Yasukazu Hijikata; Tsukasa Kamitani; Miho Sekiguchi; Koji Otani; Shin-Ichi Konno; Misa Takegami; Shunichi Fukuhara; Yosuke Yamamoto
Journal:  BMJ Open       Date:  2022-03-31       Impact factor: 2.692

4.  Low alanine aminotransferase as a risk factor for chronic obstructive pulmonary disease in males.

Authors:  Yong Jun Choi; Do Sun Kwon; Taehee Kim; Jae Hwa Cho; Hyung Jung Kim; Min Kwang Byun; Hye Jung Park
Journal:  Sci Rep       Date:  2021-07-21       Impact factor: 4.379

5.  Alanine Aminotransferase and 20-Year Risk of Major Chronic Diseases and Death in a Healthy Cohort Aged 30 to 49 Years.

Authors:  Morten Daniel Jensen; Torsten Lauritzen; Hendrik Vilstrup; Peter Jepsen
Journal:  Clin Epidemiol       Date:  2020-03-31       Impact factor: 4.790

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.